Regarding Duodopa, Abbott had its third quarter conference call yesterday. I don't know what was released but they said in the months prior that they expected to make application for approval to the FDA at the end of the year. Well c'mon folks this thing is in some 30 countries outside the US and it was "fast tracked" way back around 2006! There are few other things on in the pipeline. I read that the extended release carbidopa/levodopa is to be on the market some time around the end of this month. Just trying to keep up on the latest but there doesn't seem to be much.